Although various molecules are involved in NASH development and progression, the key factors are thought to be metabolic abnormalities due to hepatocyte steatosis, progression of fibrosis due to HSC activation, and inflammatory stimulation by KCs2. This evidence concerns the gene FAM111A and metabolic dysfunction-associated steatohepatitis.